Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study
Author(s) -
Elizabeth T. Rogawski McQuade,
James A Platts-Mills,
E. Ross Colgate,
Rashidul Haque,
Khalequz Zaman,
William A. Petri,
Beth D. Kirkpatrick
Publication year - 2017
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jix668
Subject(s) - vaccine efficacy , rotavirus , medicine , incidence (geometry) , rotavirus vaccine , diarrhea , clinical trial , confidence interval , immunity , vaccination , herd immunity , vaccine trial , immunology , virology , immune system , physics , optics
The low efficacy of rotavirus vaccines in clinical trials performed in low-resource settings may be partially explained by acquired immunity from natural exposure, especially in settings with high disease incidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom